График акции Rezolute, Inc.
О компании
Rezolute, Inc., a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It is also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 1 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. ПодробнееОсновные параметры
EBITDA | -0.0255 |
---|---|
Число акций ао | 0.05119 млрд |
P/BV | 10.04 |
EV/EBITDA | -0.2369 |
Цена ао | 2.12 |
ISIN | US76200L3096 |
Сайт | https://www.rezolutebio.com |
Изменение цены за день: | -23.45% (5.16) |
---|---|
Изменение цены за неделю: | -30.94% (5.72) |
Изменение цены за месяц: | +49.06% (2.65) |
Изменение цены за 3 месяца: | +121.91% (1.78) |
Изменение цены за полгода: | +348.86% (0.88) |
Изменение цены за год: | +92.68% (2.05) |
Изменение цены с начала года: | +334.07% (0.91) |
Все параметры ⇨
Оценка
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
Основные владельцы
Институционалы | Объем | Доля, % |
---|---|---|
Federated Hermes, Inc. | 10154327 | 0 |
Vivo Capital, LLC | 3242842 | 38.52 |
Nantahala Capital Management, LLC | 3075414 | 36.53 |
Stonepine Capital Management, LLC | 2768656 | 32.89 |
First Manhattan Company | 2680978 | 31.85 |
Blackstone Inc | 1537684 | 18.27 |
Vanguard Group Inc | 1407652 | 16.72 |
Caxton Corporation | 1318967 | 15.67 |
Sphera Funds Management Ltd. | 996710 | 11.84 |
Adage Capital Partners GP L.L.C. | 631690 | 7.5 |
Похожие компании
Руководство компании
Руководитель | Должность | Оплата | Год рождения |
---|---|---|---|
Mr. Nevan Charles Elam J.D. | Founder, CEO & Acting Chairman of the Board | 973.65k | 1967 (57 лет) |
Dr. Brian Kenneth Roberts M.D. | Chief Medical Officer | 738.86k | 1975 (49 лет) |
Dr. Davelyn Eaves Hood M.B.A., M.D. | Director and Head of Scientific & Patient Affairs | N/A | |
Mr. Michael R. Deperro | Senior VP & Head of Corporate Development | N/A | |
Mr. Michael Covarrubias | Senior VP & Head of Program & Portfolio Management | N/A | |
Mr. Chris Milks | VP & Head of Finance | N/A | |
Dr. Raj Agrawal M.D. | VP & Head of Ophthalmological Clinical Development | N/A | |
Ms. Robyn Sweinhart | VP & Head of Quality | N/A | |
Ms. Erin O'Boyle | Senior VP & Head of Clinical Operations | N/A | |
Mr. Daron G. Evans M.B.A., M.S. | Chief Financial Officer | N/A | 1974 (50 лет) |
Информация о компании
Адрес: United States, Redwood City. CA, 201 Redwood Shores Parkway - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.rezolutebio.com
Сайт: https://www.rezolutebio.com